1996 1997> 1998> 1999> 2000> 2001>

 
The National AIDS Treatment Advocacy Project - NATAP - provides the latest in HIV and AIDS drug research and treatment information as well as comprehensive reports and developments from the Fifth Retroviruses and Opportunistic Infections conference, as well as from the ICAR, ICAAC, IDSA, European and International HIV and AIDS conferences, and from other sources.

     1996

POST VANCOUVER TREATMENT REPORTS

pdf
pdf
pdf
pdf
pdf
pdf
pdf
pdf
pdf
  • Nelfinavir: Preliminary Efficacy & Safety Data Update (9/3/96)
pdf
pdf
pdf
pdf
  • 1592U89: An update of preliminary safety & antiviral data (8/9/96)
pdf
pdf
pdf
pdf
pdf
pdf
  • Ritonavir, ddC and AZT:  (7/18/96) Abbott French Study #208 of Triple Therapy, presented at Vancouver Abbott Symposium July 10, 1996
pdf
4th RETROVIRUSES & OPPORTUNISTIC INFECTIONS CONFERENCE

pdf
pdf
pdf
pdf

3rd INTERNATIONAL CONGRESS ON DRUG THERAPY IN HIV INFECTION
Birmingham, Eng.              

pdf
pdf
pdf

INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,  New Orleans

pdf
pdf

XI INTERNATIONAL CONFERENCE ON AIDS
Vancouver, July 9-12, 1996

pdf
pdf
pdf
pdf
pdf
pdf
pdf
pdf

REPORTS from the HUMAN RETROVIRUS CONFERENCE
Washington, DC.,  January 28-February 1, 1996

  • 1st day of conference protease inhibitors; data on Merck Crixivan studies; early intervention; rotinavir; IL-2.
pdf
  • 2nd day of conference viral load tests, disease progression and survival; clinical endpoint studies; early intervention.
pdf
  • 3rd and 4th days of conference viral load, disease progression and survival; application for approval of viral load test; data on ritonavir/AZT/ddC study; Crixivan/AZT/ddI study; Agouron's Viracept/d4T study; Crixivan/AZT/3TC study.
pdf

You can download these files to your computer with Adobe Acrobat Reader (TM) format for easy printing by clicking on pdf .
To download Adobe Acrobat Reader software for free, click on the icon below.
1996 1997> 1998> 1999> 2000> 2001>